Cumulative vulnerabilities and smoking abstinence: A test from a randomized clinical trial
Behav Res Ther. 2023 Feb 1;162:104272. doi: 10.1016/j.brat.2023.104272. Online ahead of print.ABSTRACTSmoking cessation is often associated with socioeconomic and intrapersonal vulnerabilities such as psychopathology. Yet, most research that focuses on predicting smoking cessation outcomes tends focus on a small number of possible vulnerabilities. In a secondary data analysis, we developed and empirically evaluated a comprehensive, cumulative vulnerability risk composite reflecting psychologically based transdiagnostic processes, social determinants of health, and psychopathology. Participants were adult smokers who responded to study advertisements (e.g., flyers, newspaper ads, radio announcements) for an in-person delivered 4-session smoking cessation trial (N = 267; 47% female; Mage = 39.4, SD = 13.8). Results indicated that the decline in point prevalence abstinence (PPA) from quit week to 6-month post-quit was statistically significant (p < .001). There were statistically significant effects of cumulative risk score on the intercept (p < .001) and slope (p = .01). These findings were evident in unadjusted and adjusted (controlling for sex, treatment condition, and nicotine dependence) models. The present results indicate smokers with greater cumulative vulnerability demonstrated poorer smoking cessation outcomes. There may be clinical advantages to better understanding cumulative vulnerability among treatment-seeking smokers and other smoking populations to enhance...
Source: Behaviour Research and Therapy - Category: Psychiatry & Psychology Authors: Michael J Zvolensky Jafar Bakhshaie Lorra Garey Brooke Y Kauffman Luke F Heggeness Norman B Schmidt Source Type: research
More News: Advertising | Clinical Trials | International Medicine & Public Health | Nicotine | Psychology | Smokers | Statistics | Study